Sasaki Y - Search Results

1

A phase I/II pharmacokinetics/pharmacodynamics study of irinotecan combined with S-1 for recurrent/metastatic breast cancer in patients with selected UGT1A1 genotypes (the JBCRG-M01 study).

Ishiguro H, Saji S, Nomura S, Tanaka S, Ueno T, Onoue M, Iwata H, Yamanaka T, Sasaki Y, Toi M. Ishiguro H, et al. Among authors: sasaki y. Cancer Med. 2017 Dec;6(12):2909-2917. doi: 10.1002/cam4.1258. Epub 2017 Nov 13. Cancer Med. 2017. PMID: 29131533 Free PMC article. Clinical Trial.

2

[Recent perspectives second-line chemotherapy for breast cancer].

Fujiuchi N, Ohokubo K, Saeki T, Sasaki Y. Fujiuchi N, et al. Among authors: sasaki y. Gan To Kagaku Ryoho. 2005 Jan;32(1):11-4. Gan To Kagaku Ryoho. 2005. PMID: 15675574 Review. Japanese.

3

Pharmacokinetic and pharmacodynamic comparison of fluoropyrimidine derivatives, capecitabine and 5'-deoxy-5-fluorouridine (5'-DFUR).

Ebi H, Sigeoka Y, Saeki T, Kawada K, Igarashi T, Usubuchi N, Ueda R, Sasaki Y, Minami H. Ebi H, et al. Among authors: sasaki y. Cancer Chemother Pharmacol. 2005 Aug;56(2):205-11. doi: 10.1007/s00280-004-0934-7. Epub 2005 Apr 21. Cancer Chemother Pharmacol. 2005. PMID: 15844007 Clinical Trial.

4

Pharmacokinetics and pharmacodynamics of protein-unbound docetaxel in cancer patients.

Minami H, Kawada K, Sasaki Y, Igarashi T, Saeki T, Tahara M, Itoh K, Fujii H. Minami H, et al. Among authors: sasaki y. Cancer Sci. 2006 Mar;97(3):235-41. doi: 10.1111/j.1349-7006.2006.00166.x. Cancer Sci. 2006. PMID: 16542221 Free PMC article.

5

Simple combinations of 5-FU pathway genes predict the outcome of metastatic gastric cancer patients treated by S-1.

Ichikawa W, Takahashi T, Suto K, Shirota Y, Nihei Z, Shimizu M, Sasaki Y, Hirayama R. Ichikawa W, et al. Among authors: sasaki y. Int J Cancer. 2006 Oct 15;119(8):1927-33. doi: 10.1002/ijc.22080. Int J Cancer. 2006. PMID: 16736497

6

Pharmacogenetic impact of polymorphisms in the coding region of the UGT1A1 gene on SN-38 glucuronidation in Japanese patients with cancer.

Araki K, Fujita K, Ando Y, Nagashima F, Yamamoto W, Endo H, Miya T, Kodama K, Narabayashi M, Sasaki Y. Araki K, et al. Among authors: sasaki y. Cancer Sci. 2006 Nov;97(11):1255-9. doi: 10.1111/j.1349-7006.2006.00321.x. Epub 2006 Sep 12. Cancer Sci. 2006. PMID: 16965601 Free PMC article.

7

Genetic linkage of UGT1A7 and UGT1A9 polymorphisms to UGT1A1*6 is associated with reduced activity for SN-38 in Japanese patients with cancer.

Fujita K, Ando Y, Nagashima F, Yamamoto W, Eodo H, Araki K, Kodama K, Miya T, Narabayashi M, Sasaki Y. Fujita K, et al. Among authors: sasaki y. Cancer Chemother Pharmacol. 2007 Sep;60(4):515-22. doi: 10.1007/s00280-006-0396-1. Epub 2007 Apr 4. Cancer Chemother Pharmacol. 2007. PMID: 17406868

8

A phase I dose-escalation study of ZD6474 in Japanese patients with solid, malignant tumors.

Tamura T, Minami H, Yamada Y, Yamamoto N, Shimoyama T, Murakami H, Horiike A, Fujisaka Y, Shinkai T, Tahara M, Kawada K, Ebi H, Sasaki Y, Jiang H, Saijo N. Tamura T, et al. Among authors: sasaki y. J Thorac Oncol. 2006 Nov;1(9):1002-9. J Thorac Oncol. 2006. PMID: 17409986 Free article. Clinical Trial.

9

Phase II study of gemcitabine monotherapy as a salvage treatment for Japanese metastatic breast cancer patients after anthracycline and taxane treatment.

Suzuki Y, Tokuda Y, Fujiwara Y, Iwata H, Sasaki Y, Saji S, Aogi K, Nambu Y, Suri A, Saeki T, Takashima S. Suzuki Y, et al. Among authors: sasaki y. Jpn J Clin Oncol. 2009 Nov;39(11):699-706. doi: 10.1093/jjco/hyp103. Epub 2009 Sep 22. Jpn J Clin Oncol. 2009. PMID: 19776022 Clinical Trial.

10

UGT1A1*1/*28 and *1/*6 genotypes have no effects on the efficacy and toxicity of FOLFIRI in Japanese patients with advanced colorectal cancer.

Sunakawa Y, Ichikawa W, Fujita K, Nagashima F, Ishida H, Yamashita K, Mizuno K, Miwa K, Kawara K, Akiyama Y, Araki K, Yamamoto W, Miya T, Narabayashi M, Ando Y, Hirose T, Saji S, Sasaki Y. Sunakawa Y, et al. Among authors: sasaki y. Cancer Chemother Pharmacol. 2011 Aug;68(2):279-84. doi: 10.1007/s00280-010-1485-8. Epub 2010 Oct 19. Cancer Chemother Pharmacol. 2011. PMID: 20957480

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

6,045 results

Search Page